Related Experiment Videos
In-vitro T cell mediated function in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases
|February 1, 1981
Summary
Peripheral blood lymphocytes from rheumatoid arthritis patients showed diminished responses to phytohaemagglutinin (PHA) stimulation. Serum from these patients blocked PHA responsiveness in normal lymphocytes, suggesting serum factors impair T cell activity in rheumatoid arthritis.
Area of Science:
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
- T cell dysfunction is implicated in the pathogenesis of RA, but the underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate in-vitro lymphocyte function in patients with active rheumatoid arthritis.
- To identify potential factors in rheumatoid arthritis serum that may affect T cell responsiveness.
Main Methods:
- Peripheral blood lymphocytes from RA patients and healthy controls were cultured in a serum-free system.
- Lymphocyte proliferation was measured after stimulation with phytohaemagglutinin (PHA).
- The effect of RA patient serum on PHA responsiveness of normal lymphocytes was assessed.
Main Results:
- Lymphocytes from 16 out of 17 active RA patients exhibited diminished PHA responsiveness in vitro.
- Normal PHA responsiveness was observed in isolated E rosette forming cells from RA patients, suggesting intact T cell function.
- Preincubation with serum from active RA patients significantly blocked PHA responsiveness in normal lymphocytes.
Conclusions:
- Reduced T cell reactivity in rheumatoid arthritis may be attributed to serum blocking factors.
- These findings suggest a potential immunomodulatory role for serum components in RA pathogenesis.
- Further research is warranted to identify and characterize these serum blocking factors.